In vivo degradation of poly (ε-caprolactone) films in Gastro Intestinal (GI) tract
Source abstract
Abstract
Abstract The degradation of PCL implant in gastrointestinal tract (stomach and intestine) was investigated in vivo. The biodegradation of PCL films after implantation in stomach and intestinal part of rats were investigated. At 3, 7, 17 and 28 days post implantation, the films were retrieved and evaluated for studying the degradation rate. The comparison of results revealed that PCL degraded more in intestinal region than in stomach. The extent of degradation was determined by measuring the change in weight loss, crystallinity, morphology and molecular weight distribution. In GI tract, the explanted PCL films from both intestine and stomach followed different degradation pathway, at different pH range and enzymes produced distinct morphology and crystallinity. Histological examination of the in vivo tissue samples revealed mild inflammation and negligible adverse effects. When results compared to polymer films degraded at stomach, the pancreatic lipase enhanced the weight loss of PCL films in intestine. Degraded PCL films in intestine showed enzymatic surface erosion by lipase as well as hydrolytic mechanism in slightly alkaline environment whereas in stomach the results are consistent with bulk erosion. In both intestine and stomach, the polymer films presented a significant decrease in molecular weight distribution.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: biodegradable polymer synthesis and properties · Electrospun Nanofibers in Biomedical Applications · Nanocomposite Films for Food Packaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. On the nature of biomaterials10.1016/j.biomaterials.2009.07.027 ↗
2. Williams · 1999
3. Solvent-dependent properties of electrospun fibrous composites for bone tissue regeneration10.1016/j.actbio.2009.07.028 ↗
4. The synergic effect of polylactide fiber and calcium phosphate particle reinforcement in poly ε-caprolactone-based composite scaffolds10.1016/j.actbio.2008.05.013 ↗
5. Preparation and degradation of L-lactide and ε-caprolactone homo and copolymer films10.1016/S0141-3910(01)00242-7 ↗
6. In vitro degradation of poly(caprolactone), poly(lactide) and their co-polymers: influence of composition, temperature and morphology10.1016/S1381-5148(96)00081-8 ↗
7. Comparison of thermal characteristics and degradation properties of epsilon-caprolactone copolymers10.1002/(SICI)1097-4636(19991205)47:3<420::AID-JBM18>3.0.CO;2-7 ↗
8. One-step route to α-hydroxyl-ω-(carboxylic acid) polylactones using catalysis by decamolybdate anion10.1021/ma0491098 ↗
9. Aliphatic polyesters. I. The degradation of poly(epsiloncaprolactone) in vivo10.1002/app.1981.070261124 ↗
10. The in vivo degradation, absorption and excretion of PCL-based implant10.1016/j.biomaterials.2005.09.019 ↗
11. Mechanisms of polymer degradation in implantable devices. 1. Poly(caprolactone)10.1016/0142-9612(93)90063-8 ↗
12. A comparison of the effect of pH on the biodegradation of two synthetic absorbable sutures10.1097/00000658-198201001-00009 ↗
13. Physicochemical characterisation of degrading polycaprolactone scaffolds10.1016/j.polymdegradstab.2010.09.007 ↗
14. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update10.1007/s11095-008-9569-4 ↗
15. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms10.1023/A:1011984216775 ↗
16. Biomaterials in orthopaedics10.1098/rsif.2008.0151 ↗
17. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells10.1016/j.biomaterials.2004.03.005 ↗
18. Kim · Ann. Surg. · 1998 · 228 · 810.1097/00000658-199807000-00002 ↗
19. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering10.1038/6146 ↗
20. In vivo and in vitro degradation of poly[50/50(85/15L/D)LA/ϵ-CL], and the implications for the use in nerve reconstruction10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.0.CO;2-Z ↗
21. Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model10.1002/(SICI)1097-4636(19970915)36:4<536::AID-JBM12>3.0.CO;2-8 ↗
22. Acid- and base-catalyzed hydrolyses of aliphatic polycarbonates and polyesters10.1016/j.cattod.2006.02.060 ↗
23. A comparative study on poly (ε-caprolactone) film degradation at extreme pH values10.1016/j.polymdegradstab.2016.06.005 ↗
24. Dynamics of in vitro polymer degradation of polycaprolactone-based scaffolds: accelerated versus simulated physiological conditions10.1088/1748-6041/3/3/034108 ↗
25. Degradation of cross-linked aliphatic polyester composed of poly(ε-caprolactone-co-d, l-lactide) depending on the thermal properties10.1016/j.polymdegradstab.2008.12.014 ↗
26. The effect of pH on the hydrolytic degradation of poly(ε-caprolactone)-block-poly(ethylene glycol) copolymers10.1002/app.37712 ↗
27. Synthesis of low molecular-weight copoly(l-lactic acid epsilon-caprolactone) by direct copolycondensation in the absence of catalysts, and enzymatic degradation of the polymers10.1016/0032-3861(90)90031-S ↗
28. Influence of different physicochemical conditions on the release of indium oxine from nanocapsules10.1002/(SICI)1097-4636(19980315)39:4<588::AID-JBM13>3.0.CO;2-3 ↗
29. Enzymatic degradation of block copolymers prepared from ε-caprolactone and poly(ethylene glycol)10.1021/bm010168s ↗
30. Enzymatic degradation of poly(epsilon-caprolactone)/poly(DL-lactide) blends in phosphate buffer solution10.1016/S0032-3861(98)00549-7 ↗
31. In situ investigations on enzymatic degradation of poly (ε-caprolactone)10.1016/j.polymer.2007.08.054 ↗
32. Enzymatic degradation of poly(ε-caprolactone) and cellulose acetate blends by lipase and α-amylase10.1016/j.polymertesting.2006.10.007 ↗
33. Synthesis, characterization and biodegradability of poly(ethylene succinate)/poly(ε-caprolactone) block copolymers10.1016/S0032-3861(02)00433-0 ↗
34. The performance of poly-ε-caprolactone scaffolds in a rabbit femur model with and without autologous stromal cells and BMP410.1016/j.biomaterials.2007.03.011 ↗
35. Enzymatic degradation of microbial poly(3-hydroxybutyrate) films10.1002/macp.1992.021930105 ↗
36. Ex vivo evaluation of biodegradable poly(ε-caprolactone) films in digestive fluids10.1016/j.apsusc.2014.06.082 ↗
37. Enzymatic degration of poly(ε-caprolactone) film in phosphate buffer solution containing lipases10.1016/S0141-3910(96)00208-X ↗
38. The biodegradation of amorphous and crystalline regions in film-blown poly (ϵ-caprolactone)10.1016/S0032-3861(99)00278-5 ↗
39. Structure-property relationships in the case of the degradation of massive poly (a-hydroxy acids) in aqueous media, Part 3: influence of the morphology of poly (L-lactic acid)10.1007/BF00701077 ↗
40. Hydrolytic and enzymatic degradation of a poly(ε-caprolactone) network10.1016/j.polymdegradstab.2012.05.038 ↗
41. Influence of polymer processing technique on long term degradation of poly(ε-caprolactone) constructs10.1016/j.polymdegradstab.2012.10.030 ↗
42. Schrader · 1995
43. FTIR study of polycaprolactone chain organization at interfaces10.1016/j.jcis.2004.02.001 ↗
44. Monte Carlo simulations of polymer degradations. 1. Degradations without volatilization10.1021/ma00209a035 ↗
45. Pancreatin enhanced erosion of and macromolecule release from 2,2-bis(2-oxazoline)-linked poly ((ε-caprolactone)10.1016/S0168-3659(02)00372-3 ↗
46. Modification of the rates of chain cleavage of poly(ε-caprolactone) and related polyesters in the solid state10.1016/0168-3659(87)90020-4 ↗
47. Technique to control pH in vicinity of biodegrading PLA-PGAimplants10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U ↗
48. The intracellular degradation of poly(epsilon-caprolactone)10.1002/jbm.820190408 ↗
49. In vitro/In vivo comparison of cefuroxime release from polycaprolactone (PCL)/Calciumsulfate (CaS) implants for osteomyelitis treatment10.1002/bab.1118 ↗
50. Fabrication and characterization of electrospun curcumin-loaded polycaprolactone-polyethylene glycol nanofibers for enhanced wound healing10.1007/s13233-014-2179-6 ↗
51. Curcumin loaded poly(ε-caprolactone) nanofibers: diabetic wound dressing with antioxidant and, anti-inflammatory properties10.1111/j.1440-1681.2009.05216.x ↗
52. The in vivo stability of electrospun polycaprolactone- collagen scaffolds in vascular reconstruction10.1016/j.biomaterials.2008.10.006 ↗